Baijiayun Group (RTC) shares were up 66% in recent Thursday premarket activity, after it said overnight it partnered with Beijing Xinlantian Education Technology to create artificial intelligence-driven rehabilitation programs for children with autism.
UniQure (QURE) stock jumped more than 49% after saying its experimental gene therapy, AMT-130, received breakthrough therapy designation from the US Food and Drug Administration to treat Huntington's disease.
Eli Lilly (LLY) shares rose 13%, after the drug manufacturer said its drug orforglipron met primary and secondary endpoints compared with a placebo in a phase 3 trial evaluating its safety and efficacy in adults with type 2 diabetes and inadequate glycemic control with diet and exercise alone.
Kosmos Energy (KOS) stock was 7.2% higher after the company and BP (BP) said that the first cargo of liquefied natural gas from the Greater Tortue Ahmeyim project, offshore Mauritania and Senegal, has been loaded.
Charles Schwab (SCHW) shares advanced over 4% after it posted higher Q1 adjusted earnings and net revenue from a year earlier.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。